HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Masashi Mizokami Selected Research

vanitaracin A

12/2015A Novel Tricyclic Polyketide, Vanitaracin A, Specifically Inhibits the Entry of Hepatitis B and D Viruses by Targeting Sodium Taurocholate Cotransporting Polypeptide.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Masashi Mizokami Research Topics

Disease

112Infections
08/2022 - 01/2000
51Chronic Hepatitis C
01/2021 - 10/2003
44Hepatocellular Carcinoma (Hepatoma)
01/2021 - 01/2000
37Hepatitis B
04/2022 - 08/2004
36Chronic Hepatitis B
07/2022 - 01/2003
28Liver Cirrhosis (Hepatic Cirrhosis)
07/2022 - 06/2002
28Hepatitis
05/2021 - 11/2003
28Fibrosis (Cirrhosis)
01/2021 - 07/2003
21Liver Diseases (Liver Disease)
07/2018 - 01/2002
15Chronic Hepatitis (Chronic Active Hepatitis)
07/2022 - 06/2002
15Neoplasms (Cancer)
11/2021 - 09/2008
14Hepatitis C
10/2020 - 11/2004
12Hemorrhage
01/2017 - 05/2005
11COVID-19
08/2022 - 08/2020
10Disease Progression
01/2022 - 12/2004
10Carcinogenesis
05/2019 - 04/2007
6Lymphoma (Lymphomas)
01/2020 - 07/2009
6Virus Diseases (Viral Diseases)
01/2013 - 12/2002
5Hypertension (High Blood Pressure)
05/2021 - 01/2013
5Inflammation (Inflammations)
05/2019 - 07/2008
5Non-alcoholic Fatty Liver Disease
07/2018 - 07/2015
5Liver Neoplasms (Liver Cancer)
07/2018 - 08/2002
5Persistent Infection
10/2017 - 01/2002
5Anemia
03/2013 - 05/2005
5Massive Hepatic Necrosis
10/2012 - 05/2004
4Obesity
05/2021 - 04/2007
4Diverticular Diseases
10/2015 - 10/2014
4HIV Infections (HIV Infection)
01/2014 - 09/2003
4Hemolytic Anemia
03/2013 - 11/2010
4Coinfection
01/2012 - 04/2002
4Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
06/2011 - 10/2006
4Viremia
01/2011 - 10/2003
3Hematologic Neoplasms (Hematological Malignancy)
08/2022 - 03/2011
3Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2022 - 08/2015
3Fever (Fevers)
01/2022 - 09/2008
3Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
12/2015 - 03/2014
3Diverticulum
11/2015 - 01/2013

Drug/Important Bio-Agent (IBA)

49InterferonsIBA
04/2022 - 12/2003
38Hepatitis B Surface Antigens (HBsAg)FDA Link
07/2022 - 08/2002
37DNA (Deoxyribonucleic Acid)IBA
05/2021 - 01/2002
34Ribavirin (Virazole)FDA LinkGeneric
07/2018 - 02/2005
32Antiviral Agents (Antivirals)IBA
05/2021 - 01/2003
23Hepatitis B e AntigensIBA
01/2019 - 01/2002
19RNA (Ribonucleic Acid)IBA
08/2022 - 08/2003
19Biomarkers (Surrogate Marker)IBA
01/2021 - 04/2011
18Proteins (Proteins, Gene)FDA Link
04/2022 - 12/2002
13Lamivudine (Epivir)FDA Link
06/2011 - 11/2003
12Alanine Transaminase (SGPT)IBA
05/2021 - 06/2002
11Pharmaceutical PreparationsIBA
12/2015 - 09/2003
10Rituximab (Mabthera)FDA Link
08/2022 - 07/2009
10AntibodiesIBA
04/2022 - 04/2007
10AntigensIBA
01/2022 - 06/2004
10CytokinesIBA
01/2022 - 10/2003
10wisteria lectinIBA
05/2019 - 11/2014
10Carrier Proteins (Binding Protein)IBA
05/2019 - 01/2013
9Transaminases (Aminotransferases)IBA
07/2009 - 08/2004
8Polysaccharides (Glycans)IBA
01/2019 - 03/2009
7VaccinesIBA
08/2022 - 05/2006
7Monoclonal AntibodiesIBA
04/2022 - 03/2014
7SofosbuvirIBA
07/2018 - 11/2014
6NucleosidesIBA
07/2022 - 02/2015
6NucleotidesIBA
07/2022 - 01/2006
6Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2021 - 01/2013
5Interferon LambdaIBA
07/2022 - 05/2010
5entecavirFDA Link
07/2022 - 06/2011
5sodium-bile acid cotransporterIBA
03/2020 - 05/2014
5ledipasvirIBA
01/2017 - 06/2015
5EnzymesIBA
01/2016 - 11/2007
5LectinsIBA
03/2014 - 01/2011
5Interferon-alpha (Interferon Alfa)IBA
03/2013 - 04/2005
4Therapeutic UsesIBA
06/2021 - 03/2007
4ChemokinesIBA
01/2021 - 01/2016
4sofosbuvir drug combination ledipasvirIBA
01/2021 - 06/2015
4ORALIT (ORS)IBA
11/2015 - 12/2013
4Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
10/2015 - 10/2014
4SteroidsIBA
09/2015 - 07/2009
4Glycoproteins (Glycoprotein)IBA
03/2014 - 01/2011
4Inosine TriphosphataseIBA
03/2013 - 11/2010
4Complementary DNA (cDNA)IBA
10/2012 - 01/2006
4Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
06/2011 - 10/2006
4acarboxyprothrombin (PIVKA)IBA
03/2009 - 07/2004
3nasIBA
07/2022 - 07/2007
3Membrane Proteins (Integral Membrane Proteins)IBA
04/2022 - 01/2017
3Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
10/2021 - 10/2020
3Circular DNAIBA
01/2021 - 05/2004
3Nucleic AcidsIBA
10/2019 - 06/2004
3HLA Antigens (Human Leukocyte Antigens)IBA
01/2018 - 01/2014
3HLA-DP Antigens (HLA-DP)IBA
10/2017 - 01/2012
3AlbuminsIBA
11/2016 - 11/2014
3Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
11/2016 - 10/2014
3Macrophage Colony-Stimulating FactorIBA
03/2016 - 03/2014
3Hyaluronic Acid (Hyaluronan)IBA
01/2016 - 10/2012
3CCR4 ReceptorsIBA
12/2015 - 03/2014
3mogamulizumabIBA
12/2015 - 03/2014
3BilirubinIBA
11/2015 - 07/2009
3Adrenal Cortex Hormones (Corticosteroids)IBA
10/2015 - 01/2013

Therapy/Procedure

76Therapeutics
08/2022 - 01/2003
16Drug Therapy (Chemotherapy)
05/2021 - 09/2008
5Blood Transfusion (Blood Transfusions)
07/2015 - 01/2000
3Length of Stay
10/2015 - 02/2015